超声波特征可以预测对生物治疗的反应 严格规定克罗恩病的治疗方法
1Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Clinical and translational gastroenterology
|July 8, 2024
概括
超声波特征,如爬行脂肪包装角度,可以预测克罗恩病 (CD) 狭窄的手术结果. 这种成像有助于识别可能需要手术或通过生物疗法实现缓解的患者.
科学领域:
- 胃肠病学 胃肠病学
- 医疗成像医学成像
- 炎症性肠道疾病研究研究
背景情况:
- 紧张是克罗恩病 (CD) 的常见并发症.
- 对生物疗法的狭窄反应的准确预测对于治疗决策至关重要.
- 这项研究调查了超声波在预测CD狭窄的结果中的作用.
研究的目的:
- 确定肠道超声波特征的狭窄和CD患者的治疗结果之间的关联.
- 识别超声波标记,预测需要手术或对生物治疗的反应.
主要方法:
- 连续患有症状性狭窄症的CD患者进行生物治疗的回顾性分析.
- 基线肠道超声波以评估收缩特征 (壁壁厚度,长度,血管性,爬行脂肪角度).
- 随访至少1年以记录结果 (手术,缓解,粘膜愈合).
主要成果:
- 爬行脂肪包装角度> 180°和高的林伯格得分独立预测了手术 (AUC 0.771).
- 爬行脂肪> 180°与手术风险增加显著相关 (HR 5.2,P=0.03).
- 爬行脂肪也与无类固醇临床缓解 (P=0.015) 和粘膜愈合 (P=0.06) 有显著的关联.
结论:
- 肠道超声波特征,特别是爬行脂肪,可以预测患有克罗恩病的患者的治疗结果.
- 超声波可以帮助优化CD狭窄的治疗策略.
- 这种成像模式为管理CD并发症提供了有价值的预后信息.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
128
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
128
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
114
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
114
Ultrasound II: Endoscopic Ultrasound and FibroScan
95
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
95
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Ultrasonography
4.4K
Ultrasonography is an imaging technique that uses high-frequency sound waves to visualize the body's internal structures. It is a non-invasive and safe procedure that does not involve the use of ionizing radiation, making it widely used in various medical fields. Ultrasonography is used to study heart function, blood flow in the neck or extremities, certain conditions such as gallbladder disease, and fetal growth and development.
During an ultrasonography procedure, a handheld device called...
During an ultrasonography procedure, a handheld device called...
4.4K


